Transitional Treatment of Adolescents in Family Therapy

Substance Abuse Clinical Trial

— Transitions  

Official title:

Transitional Treatment of Adolescents in Family Therapy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00680381
• Other study ID #: DA15762
• Secondary ID: R01DA015762
• Status: Completed
• Phase: Phase 1
• First received: May 16, 2008
• Last updated: August 4, 2014
• Start date: January 2004
• Est. completion date: July 2014

Study information

• Verified date: August 2014
• Source: Oregon Research Institute
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to test different treatments to reduce relapse for drug-abusing adolescents who have completed family therapy. Adolescents receive 12 weeks of family therapy, designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use. Then they are randomly assigned to receive one of three eight-week follow-up treatments: phone calls from a project therapist, group therapy, or a customized schedule of therapist visits with the adolescent, the adolescent's family and teachers, coaches, probation officers and others who can help the adolescent reach or maintain abstinence. Families are assessed using questionnaires and interviews before, during and after treatment, to provide information about family functioning, the adolescent's drug use, the adolescent's peers and other factors that may contribute to treatment success or failure. Adolescents also provide urine specimens for drug screening at assessment visits. Study investigators expect the study will show that a functional family environment and insulating adolescents from the influence of peers who use drugs will help prevent relapse for adolescents who have received family therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 90
• Est. completion date: July 2014
• Est. primary completion date: July 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 13 Years to 18 Years

Eligibility

Inclusion Criteria:

1. At least one parent, step-parent, or surrogate parent willing to participate in the study

2. 13 to 18 years if age

3. meets DSM-IV (APA, 1994) diagnostic criteria for substance abuse or dependence

4. Lives in the Albuquerque metropolitan area or surrounding communities with a parent, step-parent, or surrogate parent; AND

5. Sufficient residential stability to permit probable contact at follow-up (e.g., not homeless at time of intake).

Exclusion Criteria:

1. Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures

2. Adolescent deemed dangerous to self or others during evaluation

3. Services other than outpatient treatment required for the adolescent (e.g., inpatient, detoxification)

4. Adolescent already has participated in treatment project at CFAR; AND

5. A sibling is already participating in project.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Substance Abuse

Intervention

Behavioral:
• MTI, Minimal Transitional Intervention
Following 12 weeks of Functional Family Therapy (FFT), semi-weekly phone calls from a therapist for eight weeks.
• GTI, Group Transitional Intervention
Following 12 weeks of FFT, weekly one-hour sessions of group therapy for eight weeks.
• STI, Systems Transitions Intervention
Following 12 weeks of FFT, an individualized eight-week series of therapist meetings with the adolescent, family, police, teachers, coaches and others who can support the adolescent's reduced drug use.

Locations

Country	Name	City	State
United States	Oregon Res. Inst. Center for Family & Adolescent Research (CFAR)	Albuquerque	New Mexico

Sponsors (1)

Lead Sponsor	Collaborator
Oregon Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Drug use levels for adolescents who have received family therapy and one of the three aftercare regimens		pretx and 6 wks, 4 , 7 and 12 mos. post initial therapy session	No